Walgreens Boots Alliance (NASDAQ: WBA) reported Q2 EPS of $1.20, $0.38 better than the analyst estimate of $0.82. Revenue for the quarter came in at $37.1 billion versus the consensus estimate of $35.9 billion.

GUIDANCE:

Walgreens Boots Alliance sees FY2024 EPS of $3.20-$3.35, versus the consensus of $3.24.

• Narrowing fiscal 2024 adjusted EPS** guidance to $3.20 to $3.35, reflecting challenging retail environment in the U.S., early wind-down of sale-leaseback program, and lower earnings due to Cencora share sales, offset by execution in pharmacy services and a lower adjusted effective tax rate**
• Maintaining U.S. Healthcare adjusted EBITDA** to be breakeven at the midpoint of the guidance range of ($50) million to $50 million

For earnings history and earnings-related data on Walgreens Boots Alliance (WBA) click here.